BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37424026)

  • 1. Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: a systematic review and meta-analysis.
    Wang G; He Y; Guo Q; Zhao Y; He J; Chen Y; Chen W; Zhou Y; Peng Z; Deng K; Guan J; Xie W; Chang P; Liu Z
    Crit Care; 2023 Jul; 27(1):275. PubMed ID: 37424026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Renal Replacement Therapy With Adsorbing Filter oXiris in Acute Kidney Injury With Septic Shock: A Retrospective Observational Study.
    Guan M; Wang H; Tang X; Zhao Y; Wang F; Zhang L; Fu P
    Front Med (Lausanne); 2022; 9():789623. PubMed ID: 35463014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal blood purification with Oxiris
    Abdelaty M; Mohamed A; Saad MO; Mitwally H; Alkadi MM; Hashim A; Al Malki H; Ali HS; Mohamed AS; Mustafa E; Alalawi A; Elshafei M; Othman M; Khatib M; Ibrahim AS
    Int J Artif Organs; 2023 Dec; 46(12):629-635. PubMed ID: 37926985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of extracorporeal blood purification with oXiris® membrane in critically ill patients: A systematic review and meta-analysis.
    Siew LY; Lee ZY; Yunos NM; Atan R; Cove ME; Lumlertgul N; Srisawat N; Hasan MS
    J Crit Care; 2024 Jun; 83():154844. PubMed ID: 38901069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study.
    Broman ME; Hansson F; Vincent JL; Bodelsson M
    PLoS One; 2019; 14(8):e0220444. PubMed ID: 31369593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CRRT with oXiris filter on hemodynamic instability in surgical septic shock with AKI: A pilot randomized controlled trial.
    Feng J; Zhang S; Ai T; Wang L; Gao Y; Li W; Zhu M
    Int J Artif Organs; 2022 Oct; 45(10):801-808. PubMed ID: 35864718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oXiris-CVVH on the Clinical Outcomes of Patients with Septic Shock: An Inverse Probability of Treatment-Weighted Analysis.
    Xie J; Xiao W; Lin J
    Blood Purif; 2022; 51(12):972-989. PubMed ID: 35649340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
    Jacobsen A; Olabi B; Langley A; Beecker J; Mutter E; Shelley A; Worley B; Ramsay T; Saavedra A; Parker R; Stewart F; Pardo Pardo J
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013130. PubMed ID: 35274741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids for treating sepsis in children and adults.
    Annane D; Bellissant E; Bollaert PE; Briegel J; Keh D; Kupfer Y; Pirracchio R; Rochwerg B
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD002243. PubMed ID: 31808551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for mortality in intensive care unit patients with sepsis combined with acute kidney injury after continuous renal replacement therapy: secondary analysis of the data from a multicenter observational study].
    Zhang Q; Fei Y; Jiang L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Feb; 31(2):155-159. PubMed ID: 30827301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].
    Chen M; Hu B; Li Q; Liu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):246-51. PubMed ID: 29917340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application value of oXiris-endotoxin adsorption in sepsis.
    Zhai Y; Pan J; Zhang C
    Am J Transl Res; 2021; 13(4):3839-3844. PubMed ID: 34017574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of oXiris-continuous hemofiltration adsorption in patients with sepsis and septic shock: A single-centre experience in China.
    Zhou Y; Wu C; Ouyang L; Peng Y; Zhong D; Xiang X; Li J
    Front Public Health; 2022; 10():1012998. PubMed ID: 36249210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The haemodynamic effects of oXiris haemofilter in septic shock patients requiring renal support: A single-centre experience.
    Lumlertgul N; Srisawat N
    Int J Artif Organs; 2021 Jan; 44(1):17-24. PubMed ID: 32393096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filter life and safety of heparin-grafted membrane for continuous renal replacement therapy - A randomized controlled trial.
    Wong ET; Ong V; Remani D; Wong WK; Haroon S; Lau T; Nyeo HQ; Mukhopadhyay A; Tan BH; Chua HR
    Semin Dial; 2021 Jul; 34(4):300-308. PubMed ID: 33556204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.
    Burton JK; Craig LE; Yong SQ; Siddiqi N; Teale EA; Woodhouse R; Barugh AJ; Shepherd AM; Brunton A; Freeman SC; Sutton AJ; Quinn TJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013307. PubMed ID: 34280303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of renal replacement therapy in patients with sepsis-associated acute kidney injury: A systematic review and meta-analysis.
    Wang Q; Liu F; Tao W; Qian K
    Aust Crit Care; 2024 Mar; 37(2):369-379. PubMed ID: 37734999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto Y; Miki S; Shimada H; Tsujimoto H; Yasuda H; Kataoka Y; Fujii T
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013330. PubMed ID: 34519356
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.